HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which lea
✦ LIBER ✦
Anticalins ® : the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies
✍ Scribed by Hohlbaum, Andreas M; Skerra, Arne
- Book ID
- 125492652
- Publisher
- Expert Reviews
- Year
- 2007
- Tongue
- English
- Weight
- 297 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1744-666X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Development of the next generation of HI
✍
Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati;
📂
Article
📅
2010
🏛
Elsevier Science
🌐
English
⚖ 522 KB
ChemInform Abstract: Development of the
✍
Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati;
📂
Article
📅
2011
🏛
John Wiley and Sons
⚖ 23 KB
👁 2 views
A novel type of receptor protein, based
✍
Steffen Schlehuber; Gerald Beste; Arne Skerra
📂
Article
📅
2000
🏛
Elsevier Science
🌐
English
⚖ 441 KB
Development and application of cytotoxic
✍
Simon E. Hufton; Nicole van Neer; Twan van den Beuken; Johan Desmet; Erwin Sablo
📂
Article
📅
2000
🏛
Elsevier Science
🌐
English
⚖ 256 KB
Phenylketonuria as a model for protein m
✍
Ania C. Muntau; Søren W. Gersting
📂
Article
📅
2010
🏛
Springer
🌐
English
⚖ 520 KB
Design and synthesis of novel polycycles
✍
Marco Derudas; Nicolino Pala; Vanna Sanna; Roberto Dallocchio; Alessandro Dessì;
📂
Article
📅
2011
🏛
Journal of Heterocyclic Chemistry
🌐
English
⚖ 379 KB
In the course of our work aimed at developing novel heterocycles of pharmaceutical interest, we designed and synthesized several polycyclic templates as potential substrates to be used in drug design. We obtained a set of condensed ring systems as versatile structural platforms to generate potential